Clinical Trials

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT04462419 2025-09-10

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Terminated

19 enrolled

CNS

Brain Neoplasms

NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

24 enrolled

CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

NCT05678322 2025-04-23

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Phase 3 Active not recruiting

26 enrolled

Prostatic Neoplasms

NCT01652196 2025-02-05

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

56 enrolled 14 charts

Phase EARLY_PHASE1 Recruiting

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05400967 2024-09-19

Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI

10 enrolled

177Lu-EB-FAPI

NCT04023240 2024-08-12

68-Ga-FAPI PET Imaging in Malignancy

Phase 2 Withdrawn

Tumor-Agnostic

Neoplasms

NCT02591654 2022-12-30

MPAK

Phase EARLY_PHASE1 Terminated

6 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

29 enrolled 10 charts

Sarcoma

Hemangiosarcoma, Sarcoma

NCT01812668 2021-08-05

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

20 enrolled 12 charts

Prostatic Neoplasms

NCT01004718 2021-05-18

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

10 enrolled 3 charts

Lymphoid

Lymphoma

NCT01807117 2021-05-18

PET-MRI in Diagnosing Patients With Colon or Rectal Cancer

15 enrolled 17 charts

Colonic Neoplasms, Rectal Neoplasms

NCT02397408 2020-11-19

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

18 enrolled 21 charts

Prostatic Neoplasms

NCT01020097 2020-04-28

Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx

5 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT02287636 2020-02-24

PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer

13 enrolled 5 charts

Tumor-Agnostic

Neoplasms

NCT01476410 2020-02-17

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Phase 2 Unknown

48 enrolled

Lymphoid

Hodgkin Disease

NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

15 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

8 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02139488 2019-06-27

Organ Motion and Early Tumor Response Measurement

Completed

80 enrolled

Esophageal Neoplasms

NCT01537107 2019-04-08

Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

Phase 1 Completed

31 enrolled

Pancreatic Neoplasms

NCT02070406 2019-02-28

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

Phase 1 Terminated

4 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01868906 2018-08-24

FMISOPETSCS

Phase 2 Terminated

6 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT02850302 2018-08-09

TRANSTEP

23 enrolled

Breast

Breast Neoplasms

NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase 1 Completed

9 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT01789892 2018-06-28

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Phase NA Withdrawn

Phase EARLY_PHASE1 Completed

Lung Neoplasms

NCT01825902 2017-11-20

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

1 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

NCT03013387 2017-08-25

Dosimetry Guided PRRT With 90Y-DOTATOC

Phase 2 Withdrawn

CNS

Medulloblastoma, Meningioma, Neuroblastoma

NCT01494012 2017-04-28

Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer

Phase 1 Terminated

1 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT02194452 2017-04-28

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Phase NA Withdrawn

CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroma, Acoustic, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Glioma, Subependymal, Gliosarcoma, Optic Nerve Glioma

NCT02440308 2017-04-11

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

10 enrolled 4 charts

Prostatic Neoplasms

NCT00564733 2017-02-10

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

55 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT02169063 2016-08-31

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT00086801 2016-07-01

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma

104 enrolled

Lymphoid

Hodgkin Disease, Lymphoma

NCT00242086 2016-06-01

Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases

7 enrolled

Colorectal Neoplasms

NCT01129206 2016-06-01

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

6 enrolled 6 charts

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Neoplasms

NCT00123747 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

23 enrolled

CNSGastrointestinalHead & NeckLymphoidThoracic

Lung Neoplasms

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase 2/3 Completed

10,838 enrolled

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT01017133 2012-09-26

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 1 Completed

56 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01482585 2011-11-30

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Unknown

200 enrolled